Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis
NCT02542787
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
160
Enrollment
INDUSTRY
Sponsor class
Conditions
Spasticity in People With Multiple Sclerosis
Interventions
DRUG:
VSN16R
OTHER:
Placebo
Sponsor
Canbex Therapeutics Ltd